Dyne Therapeutics (DYN) Total Current Liabilities (2019 - 2026)

Dyne Therapeutics' Total Current Liabilities history runs 8 years deep, the most recent figure standing at $51.2 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 51.26% year-over-year to $51.2 million; the TTM figure through Mar 2026 stood at $51.2 million (up 51.26% YoY), while the FY2025 annual figure was $50.6 million, up 19.8% from the prior year.
• Total Current Liabilities was $51.2 million for Q1 2026 at Dyne Therapeutics, up from $50.6 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $59.8 million in Q3 2025 to a low of $20.2 million in Q2 2023.
• Historically, Total Current Liabilities has averaged $35.2 million across 5 years, with a median of $29.8 million in 2024.
• Biggest YoY gain for Total Current Liabilities was 81.91% in 2023; the steepest drop was 21.08% in 2023.
• A 5-year view of Total Current Liabilities shows it stood at $28.1 million in 2022, then jumped by 81.91% to $51.1 million in 2023, then slipped by 17.3% to $42.3 million in 2024, then gained by 19.8% to $50.6 million in 2025, then gained by 1.23% to $51.2 million in 2026.
• The last three Total Current Liabilities figures came in at $51.2 million (Q1 2026), $50.6 million (Q4 2025), and $59.8 million (Q3 2025), per Business Quant data.